← Open Payments lookup

JEHAN HELMI: Open Payments

NPI 1497986285 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,378 in 73 payments from 11 companies in 2025. Trend: 2023 $53 · 2024 $112 · 2025 $1,378

Food & beverage: $1,378
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.23$426
E.R. Squibb & Sons, L.L.C.16$240
Teva Pharmaceuticals USA, Inc.7$209
ABBVIE INC.11$180
Alkermes, Inc.4$85
Luye Pharma (USA) Ltd.3$69
Neurocrine BioSciences, Inc.3$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$42
Indivior Inc.2$34
Janssen Pharmaceuticals, Inc1$24

Products named: COBENFY, REXULTI, AUSTEDO XR, VRAYLAR, ABILIFY ASIMTUFII, ABILIFY MAINTENA, ARISTADA, ERZOFRI EXTENDED-RELEASE.

Industry payments across CA — which companies pay providers there.